MedPath

Gabatreve

Brand Name: Gabatreve

Generic Name: Pregabalin

Active
Registration Number

DRP-8025-03

Dosage Form

Capsule

Issuance Date

January 31, 2023

Expiry Date

November 19, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength75 mg
PackagingAlu/Alu Blister Pack x 7's (Box of 56's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antiepileptics
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

PregabalinActive
Monograph: Pregabalin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform